Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Total Valuation
Bio-Techne has a market cap or net worth of $7.79B. The enterprise value is $11.79B.
Market Cap$7.79B
Enterprise Value$11.79B
Share Statistics
Bio-Techne has 158.09M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding158.09M
Owened by Insiders0.22%
Owened by Instutions25.68%
Financial Efficiency
Bio-Techne’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.28%.
Return on Equity (ROE)8.13%
Return on Assets (ROA)6.22%
Return on Invested Capital (ROIC)7.28%
Return on Capital Employed (ROCE)8.12%
Revenue Per Employee$385,811.29
Profits Per Employee$51,011.935
Employee Count3,100
Asset Turnover0.43
Inventory Turnover2.17
Valuation Ratios
The current PE Ratio of Bio-Techne is 67.18. Bio-Techne’s PEG ratio is -1.64.
PE Ratio67.18
PS Ratio9.74
PB Ratio5.46
Price to Fair Value5.46
Price to FCF47.83
Price to Operating Cash Flow37.77
PEG Ratio-1.64
Income Statement
In the last 12 months, Bio-Techne had revenue of $1.20B and earned $158.14M in profits. Earnings per share was $1.00.
Revenue$1.20B
Gross Profit$787.02M
Operating Income$238.38M
Pretax Income$185.79M
Net Income$158.14M
EBITDA342.06M
Earnings Per Share (EPS)1.00
Cash Flow
In the last 12 months, operating cash flow was $304.72M and capital expenditures -$50.41M, giving a free cash flow of $254.30M billion.
Operating Cash Flow$304.72M
Free Cash Flow$254.30M
Free Cash Flow per Share$1.61
Dividends & Yields
Bio-Techne pays an annual dividend of $0.32, resulting in a dividend yield of 0.65%
Dividend Per Share$0.32
Dividend Yield0.65%
Payout Ratio17.46%
Free Cash Flow Yield2.09%
Earnings Yield1.49%
Stock Price Statistics
Beta0.97
52-Week Price Change-23.66%
50-Day Moving Average62.29
200-Day Moving Average71.22
Relative Strength Index (RSI)33.04
Average Volume (3m)2.19M
Important Dates
Bio-Techne upcoming earnings date is Apr 30, 2025, Before Open.
Last Earnings DateFeb 5, 2025
Next Earnings DateApr 30, 2025
Ex-Dividend DateFeb 14, 2025
Financial Position
Bio-Techne as a current ratio of 3.87, with Debt / Equity ratio of 0.20
Current Ratio3.87
Quick Ratio2.75
Debt to Market Cap0.03
Net Debt to EBITDA0.86
Interest Coverage Ratio13.13
Taxes
In the past 12 months, Bio-Techne has paid $27.66M in taxes.
Income Tax$27.66M
Effective Tax Rate9.47%
Enterprise Valuation
Bio-Techne EV to EBITDA ratio is 37.25, with an EV/FCF ratio of 48.97.
EV to Sales9.97
EV to EBITDA37.25
EV to Free Cash Flow48.97
EV to Operating Cash Flow38.67
Balance Sheet
Bio-Techne has $177.55M in cash and marketable securities with $395.13M in debt, giving a net cash position of $217.58M billion.
Cash & Marketable Securities$177.55M
Total Debt$395.13M
Net Cash$217.58M
Net Cash Per Share$1.38
Tangible Book Value Per Share$3.74
Margins
Gross margin is 66.41%, with operating margin of 17.83%, and net profit margin of 14.50%.
Gross Margin66.41%
Operating Margin17.83%
Pretax Margin16.02%
Net Profit Margin14.50%
EBITDA Margin26.78%
EBIT Margin17.38%
Analyst Forecast
The average price target for Bio-Techne is $82.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$82.00
Price Target Upside61.67%
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast4.46%
EPS Growth Forecast-29.62%